Delivery Order 75N93024D00042-75N93024F00006

Award Date 9/20/24
Potential Completion Date 9/19/25
Potential Value $5.1M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Galveston, TX 77555, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Texas Medical Branch at Galveston (UTMB). The order, valued at $1,727,489.49, is part of a larger indefinite delivery contract (IDC) between NIAID and UTMB to provide preclinical research services related to infectious diseases. The work will support NIAID's Pre-Clinical Models of Infectious Diseases program. This...
This federal contract award to the University of Texas Medical Branch at Galveston (UTMB) is for a task order under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract. The $6,739,837 task order is for the development of medical countermeasures and animal models for biosafety level 4 (BSL-4) pathogens. The work will be performed in Galveston, Texas, and the contract has a final completion date of...
This is a $917,031 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Texas Medical Branch at Galveston (UTMB). The order is placed under NIAID's Animal Models of Infectious Diseases Indefinite Delivery Contract (IDC), a $146.3 million single-award vehicle that allows NIAID to efficiently order a range of preclinical research and development services from UTMB to support the evaluation...
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to the University of Texas Medical Branch at Galveston (UTMB), a U.S. state government medical institution and educational institution. The $417,060 delivery order was for task order funding under the NIAID Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract, with a...
This federal contract award is for a task order issued under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract. The prime contractor is the University of Texas Medical Branch (UTMB) at Galveston, a state government entity and educational institution with extensive experience supporting federal agencies in areas such as infectious disease research, clinical trials, and emergency preparedness. The...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Texas Medical Branch at Galveston (UTMB). The contract, valued at $174,528.00, is a firm fixed-price delivery order with no set-aside designation. The contractor will extract historical raw data from all studies performed under previous indefinite delivery, indefinite quantity (IDIQ) contract mechanisms. This contract is part of a larger $146.3...
This is a $1,179,674.00 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the University of Texas Medical Branch at Galveston (UTMB). The contract is for pre-clinical models of infectious diseases research and is part of NIAID's Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract vehicle, which has a total ceiling value of $2,706,323.34. UTMB, a...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,151,741.00 delivery order contract to the University of Texas Medical Branch at Galveston (UTMB) for preclinical research services related to infectious diseases. This contract is a task order under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery/indefinite quantity (IDIQ) contract. UTMB, a state controlled institution of...
This federal contract award is for the University of Texas Medical Branch at Galveston (UTMB) to provide a range of services related to biomedical research and healthcare to the National Institute of Allergy and Infectious Diseases (NIAID). The award is a Delivery Order under NIAID's Animal Models of Infectious Diseases 2010-2017 indefinite delivery contract, with a ceiling value of $1,508,894.41. The contract does not have a set-aside designation. As a major academic health center, UTMB has...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded the University of Texas Medical Branch at Galveston (UTMB) a $388,097 delivery order task order under the NIAID Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract. This contract is for pre-clinical models of infectious diseases research. The award has no set-aside designation. As a prime contractor, UTMB...
  • 75N93024D00042
    Indefinite Delivery Contract
  • 75N93024D00042-75N93024F00006
    Delivery Order

This is a task order award under a larger indefinite delivery contract (IDC) held by the University of Texas Medical Branch at Galveston (UTMB) with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health. The task order, valued at $5,130,964.00, is for work related to TASK A02 and will support the university's research and development efforts across various areas, including the development of animal models, specialized reagents, and medical countermeasures for infectious diseases. UTMB, as a state-controlled institution of higher learning, has extensive experience in biomedical research, infectious disease studies, and preclinical testing for federal agencies. This task order is not set aside and is part of a larger $146.3 million IDC that allows NIAID to efficiently acquire a range of research and development services from UTMB's specialized high-containment laboratories.

Generated 7/1/25, 6:46 AM